Correlation Between Eledon Pharmaceuticals and Rezolute

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eledon Pharmaceuticals and Rezolute at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eledon Pharmaceuticals and Rezolute into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eledon Pharmaceuticals and Rezolute, you can compare the effects of market volatilities on Eledon Pharmaceuticals and Rezolute and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eledon Pharmaceuticals with a short position of Rezolute. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eledon Pharmaceuticals and Rezolute.

Diversification Opportunities for Eledon Pharmaceuticals and Rezolute

0.45
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Eledon and Rezolute is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Eledon Pharmaceuticals and Rezolute in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rezolute and Eledon Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eledon Pharmaceuticals are associated (or correlated) with Rezolute. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rezolute has no effect on the direction of Eledon Pharmaceuticals i.e., Eledon Pharmaceuticals and Rezolute go up and down completely randomly.

Pair Corralation between Eledon Pharmaceuticals and Rezolute

Given the investment horizon of 90 days Eledon Pharmaceuticals is expected to generate 1.29 times less return on investment than Rezolute. But when comparing it to its historical volatility, Eledon Pharmaceuticals is 1.15 times less risky than Rezolute. It trades about 0.08 of its potential returns per unit of risk. Rezolute is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  181.00  in Rezolute on April 18, 2024 and sell it today you would earn a total of  283.00  from holding Rezolute or generate 156.35% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Eledon Pharmaceuticals  vs.  Rezolute

 Performance 
       Timeline  
Eledon Pharmaceuticals 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Eledon Pharmaceuticals are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very weak fundamental indicators, Eledon Pharmaceuticals displayed solid returns over the last few months and may actually be approaching a breakup point.
Rezolute 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Rezolute are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating essential indicators, Rezolute unveiled solid returns over the last few months and may actually be approaching a breakup point.

Eledon Pharmaceuticals and Rezolute Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eledon Pharmaceuticals and Rezolute

The main advantage of trading using opposite Eledon Pharmaceuticals and Rezolute positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eledon Pharmaceuticals position performs unexpectedly, Rezolute can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rezolute will offset losses from the drop in Rezolute's long position.
The idea behind Eledon Pharmaceuticals and Rezolute pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing